Visual Med (VMCS) Stock Message Board

Moderator:

Search This Board:

Last Post: 2/23/2021 3:10:17 PM - Followers: 47 - Board type: Free - Posts Today: 0

VISUALMED CLINICAL SOLUTIONS CORP.

http://visualmedclinicalsolutions.com

SHORT HISTORY:
VisualMED started its operations in 2004 in Montreal, developing (in cooperation with Cardinal Health) a full suite of clinical and medical solutions (investing $50-60 million) to help hospitals, clinics and healthcare authorities improve the efficiency of managing patients care, increasing personnel efficiency, bringing down operating cost while improving outcomes. It included a Computerized Physician Order Entry (CPOE) with powerful decision support to enable better patient care, greater safety and reduce risks due to medication errors. At the time the VisualMED solution was praised as one of the best in the market. VisualMED modules were running in 11 hospitals and 4 clinics, a.o. The Montreal Heart Institute, St. Justine's Children Hospital, The Segal Oncology Center, Royal Victoria Hospital, Physician Hospital of El Paso, Kansas Surgical and Recovery Center of Wichita, SR Rehab Center of Battle Creek, Ville Marie Breast Clinic Montreal, St. Mary's Oncology Day Center etc. Unfortunately VisualMED was not able to compete with larger companies and suffered heavy losses. Under ARRA VisualMED made a comeback in 2010-2011 but was unable to attract financing/venture capital to make a big step forward.

In 2011 VisualMED had become party to a joint venture comprising Verizon, The Veterans Hospitals and the State of Maryland. April 2012 the Maryland Center at Bowie State University issued a PR about a new partnership with Intelaform inc. and VisualMED to develop a community-based care transition program for the State of Maryland. A fabulous venture (working on projected revenue of $2 billion) collapsed when Governor O'Malley left and the funding for the project was cancelled. After this giant blow VisualMED tried to survive, fighting off losses from existing contracts and reorganisations.
The company was kept alive by loans from officials, $654,000 per 06-30-2018.

ACTUAL SITUATION:
At this moment VisualMED still owns all rights to it's set of clinical modules and the medical database. VisualMED now calls itself a medical knowledge company. End 2016 Gerard Dab said: "The Quebec government has just provided 93 million dollars to one of the world's leading research fellows in artificial intelligence and machine learning. Part of the mandate for this research will be to impact the way Healthcare is managed as well as the practice of Medicine. This is a step towards the automation of Medicine. The academics have a mandate to work with the private sector. I will be meeting with this group in order to explore how we can participate in this ground breaking initiative". Last july 2018 Gerard Dab said the following: "We are looking towards teaming up with some of the vast Networks working on an artificial intelligence in Montreal which have raised almost a billion dollars from Canadian public funds." After a long silence (2012-2017) suddenly the company comes alive, posting the annual list at the Nevada secretary of state and a reinstatement of the company per 08-31-2018.
https://newcities.org/the-big-picture-why-montreal-is-winning-the-ai-race/

WHAT'S NEXT:
January 5th 2019 CEO Gerard Dab gave an update: "Dear stakeholders and fellow shareholders In response to your many recent inquiries let me review where we stand at the onset of this new year. The company is and has been very much active, looking to revive its medical automation business after many lean years. It still holds a portfolio of valuable intellectual property regarding prevention of adverse drug events (ADE) as well as workflow solutions in the in-patient clinical setting. Since 2017 we have taken advantage of the fact that our university affiliates are world leaders in machine learning and Artificial Intelligence. We are in the process of bringing our applications up to date with artificial intelligence as well as new advances in big data analysis. The medical planning is being done in Montreal, programming will be outsourced to a Polish company for obvious benefit in terms of quality and cost-saving. We are also in the process of taking our intelligent applications originally created for clinicians and making them available to patients and citizens concerned about their health. This initiative has significant government support. We have been qualified for public funding in the amounts of 2- 2,25M most of which is made of government loans and grants. The main reason for our set back between 2011 and 2016 had been a major shift in government priorities away from seeking better outcomes and reducing deadly adverse drug events to a single-minded focus on the issue of insurance and access to care. Of course, access is an important issue but not one that benefit our clinical improvement business. Now that the issue of access has been resolved there is a renewed interest in finding solutions to our deteriorating quality of care. After 20 years of massive investments in all kinds of information technology, mostly obsolete, by health boards and hospitals, the number of deadly ADEs, adverse drug events, has not decreased in the United States and Canada. Every year half a million people continue to die from preventable adverse drug event because the combination of prescriptions is not properly monitored neither by physicians nor pharmacists. It remains the same number of preventable deaths that had been referenced in the watershed 1999 National Institute of Health report titled: “To Err is Human”. VisualMED is now turning to new advances in artificial intelligence and machine learning and possibly eventually blockchain. This makes it possible for us to put in the hands of individual patients, the very same technology tools that they can now use to monitor their own health status and to some extent monitor their prescriptions and procedures. As we know most people are not health conscious, but we believe we can rebuild our business around mothers with children, people caring about aging parents and, yes perhaps, hypochondriacs. A few hundred thousand subscribers could support a viable business model. We shall see. With my best wishes for a Happy New year Gérard Dab"

Latest news from CEO dated 02/14/2019:
Canada is accelerating its multibillion-dollar public funding of artificial intelligence and VisualMED is in the process of securing funding to help the company resort to artificial intelligence to move its clinical intelligent apps into the hands of patients. More to come soon.

VisualMED Clinical Solutions Corp. has a listing on OTC Markets (OTC:VMCS), share structure per 06-30-2018:
number of A/S: 350,000,000
number of O/S: 224,170,445 (or 146,705,186 when VSHC stake deducted)
free float : 91,009,751
(the real free float is very limited as most shares are in solid hands)

VisualMED Board of Directors:
Gerard Dab: CEO (co-founder and Chairman since its inception)
Michel Dab: treasurer
Louis Lombardo: director (Mr. Lombardo is attorney and partner at Meister Seelig & Fein,
corporate and securities law advice to clients in mergers and acquisitions,
corporate governance, public and private securities offering etc)
(VisualMED has 8 parttime consultants)

https://www.otcmarkets.com/stock/VMCS/profile

VMCS
Current Price
Volume:

Bid	Ask	Day's Range


VMCS Detailed Quote

Visual Med (VMCS)

About

Help

Educational

More